首页> 外文期刊>Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society >Use of Model for End-Stage Liver Disease Exceptions for Donation After Cardiac Death Graft Recipients Relisted for Liver Transplantation
【24h】

Use of Model for End-Stage Liver Disease Exceptions for Donation After Cardiac Death Graft Recipients Relisted for Liver Transplantation

机译:在心脏死亡移植受者重新列为肝移植后捐赠的终末期肝病例外模型中的应用

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Donation after cardiac death (DCD) liver transplantation is associated with increased biliary complications and graft failure. Yet for unclear reasons, DCD recipients relisted for transplantation have lower wait-list mortality than other retransplant candidates. We used Organ Procurement and Transplantation Network and United Network for Organ Sharing data from 2002 to 2011 to evaluate all DCD recipients relisted for transplantation to evaluate the impact of the utilization of Model for End-Stage Liver Disease (MELD) exception points on wait-list outcomes. Of 262 DCD recipients relisted for liver transplantation >2 weeks after initial transplantation, 82 (31.3%) applied for a nonstandardized MELD exception, and 68 (82.9%) had 1 exception approved. Of the relisted DCD recipients, 187 (71.4%) underwent retransplantation; among those with an approved MELD exception, 85.2% underwent retransplantation versus 57.1% of those with an exception denied and 69.4% of those not applying for an exception (P=0.02). In contrast, those receiving MELD exception points were significantly less likely to be removed from the wait list for death or clinical deterioration in comparison with those not applying for an exception (7.1% versus 19.4%, P=0.02). In multivariate models, patients with an approved exception were 3.3 times more likely to undergo retransplantation than those not applying for an exception. Standardized criteria for exception points among DCD recipients should be established to ensure uniform access to retransplantation. Liver Transpl 21:554-560, 2015. (c) 2015 AASLD.
机译:心脏死亡(DCD)肝移植后的捐赠与胆道并发症和移植物衰竭增加有关。但是由于不清楚的原因,重新移植的DCD接受者的等待名单死亡率比其他重新移植的候选人低。我们使用2002年至2011年的器官采购和移植网络以及联合网络的器官共享数据来评估所有重新列为移植的DCD接受者,以评估使用终末期肝病模型(MELD)例外点对等待名单的影响结果。在初次移植后2周内重新列为肝移植的262位DCD接受者中,有82位(31.3%)申请了非标准化的MELD例外,而68位(82.9%)批准了1次例外。在重新列出的DCD接受者中,有187例(71.4%)接受了再移植;在获得批准的MELD例外患者中,有85.2%接受了再移植,而有例外情况的患者中有57.1%接受了再移植,而没有申请例外的患者中有69.4%(P = 0.02)。相反,与那些没有申请例外的人相比,那些获得MELD例外点的人从死亡或临床恶化的等待名单中删除的可能性要小得多(7.1%对19.4%,P = 0.02)。在多变量模型中,获得批准的例外患者进行再移植的可能性是没有申请例外的患者的3.3倍。应建立DCD接受者例外点的标准化标准,以确保统一获得重新移植的机会。 Liver Transpl 21:554-560,2015.(c)2015 AASLD。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号